HKU Gets Green Light For Nasal Covid Vaccine Trials
"); jQuery("#212 h3").html("
"); });
2020-09-09 HKT 19:19
Share this story
The University of Hong Kong says mainland authorities have allowed clinical trials of a nasal spray vaccine for Covid-19 it has been developing with mainland institutions.
The State Key Laboratory of Emerging Infectious Diseases of the university's Department of Microbiology has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.
It says it is the only nasally-administered vaccine against the disease to be allowed for clinical trials so far by the National Medical Products Administration.
HSBC Launches TradeCash In Hong Kong To Accelerate Trade Finance Access
HSBC has launched a digital trade finance tool called HSBC TradeCash, allowing businesses in Hong Kong to upload sales ... Read more
HKEX And HKMA Launch Pilot On E-HKD For After-Hours Margin Payments
Hong Kong Exchanges and Clearing Limited (HKEX) and the Hong Kong Monetary Authority (HKMA) have launched a joint pilot... Read more
Can You Trust AI Agents To Stay Within Your Intent?
Checking someone’s ID at the door of a nightclub tells you who they are, but it does not tell you how they will behav... Read more
China CITIC Bank Taps Tencent Cloud For Fintech 2.0 Banking Push In Hong Kong
Tencent Cloud has signed a strategic cooperation agreement with China CITIC Bank International (CNCBI) to support the d... Read more
Payful Launches Cloud-Based Visa Charge Card Programme Via BPC SmartVista
Chinese cross-border payment company Payful has launched a cloud-native Visa charge-card programme for corporate and me... Read more
Hong Kong Banking Taskforce Convenes To Plan Northern Metropolis Financing
The Northern Metropolis Financial Advisory Taskforce held its inaugural meeting on 17 June to discuss the financing nee... Read more